Atlas Trials

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Clinical trial NCT07160179 · RECRUITING

Trial details

NCT number
NCT07160179
Sponsor
AbbVie
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Geographic AtrophyAge-Related Macular Degeneration
Start date
2025-08-13
Primary completion
2029-10-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.